VanderWeideLAFosterCJMacLarenRKiserTHFishDNMuellerSW. Evaluation of early dexmedetomidine addition to the standard of care for severe alcohol withdrawal in the ICU: a retrospective controlled cohort study. J Intensive Care Med. 2016;31(3):198–204.
2.
MuellerSWPreslaskiCRKiserTH. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal. Crit Care Med. 2014;42(5):1131–1139.
3.
SpiesCDOtterHEHüskeB. Alcohol withdrawal severity is decreased by symptom-orientated adjusted bolus therapy in the ICU. Intensive Care Med. 2003;29(12):2230–2238.
4.
GoldJARimalBNolanANelsonLS. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med. 2007;35(3):724–730.
5.
WojnarMWasilewskiDMatsumotoHCedroA. Differences in the course of alcohol withdrawal in women and men: a Polish sample. Alcohol Clin Exp Res. 1997;21(8):1351–1355.
6.
WongABenedictNJArmahizerMJKane-GillSL. Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome. Ann Pharmacother. 2015;49(1):14–19.
